Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C16H13NO2S |
| Molecular Weight | 283.345 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C(O)=O)C1=CC2=C(C=C1)N=C(S2)C3=CC=CC=C3
InChI
InChIKey=DPRKTNKWAXPYNW-UHFFFAOYSA-N
InChI=1S/C16H13NO2S/c1-10(16(18)19)12-7-8-13-14(9-12)20-15(17-13)11-5-3-2-4-6-11/h2-10H,1H3,(H,18,19)
| Molecular Formula | C16H13NO2S |
| Molecular Weight | 283.345 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Tazifylline (also known as LN 2974) is a long-acting histamine H1-receptor antagonist that was studied in clinical trials for the treatment of allergic rhinitis and asthma. In addition, this compound was studied on the itching and scratching of patients with atopic eczema. However, the further development of tazifylline appears to have been discontinued by Roche.
Originator
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Multiple-dose pharmacokinetics of the new H1-receptor antagonist tazifylline in healthy volunteers. | 1989-01-01 |
|
| Antiallergic effects of the new histamine H1-receptor antagonist tazifylline in healthy atopic and non-atopic subjects. | 1988-02 |
|
| The effect of a new non-sedative H1-receptor antagonist (LN2974) on the itching and scratching of patients with atopic eczema. | 1986-11 |
|
| Animal pharmacology of the selective histamine H1-receptor antagonist tazifylline. | 1986-04 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/2564283
10 mg b.i.d. for 8 days
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:33:00 GMT 2025
by
admin
on
Mon Mar 31 18:33:00 GMT 2025
|
| Record UNII |
S05RV1R3LZ
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C257
Created by
admin on Mon Mar 31 18:33:00 GMT 2025 , Edited by admin on Mon Mar 31 18:33:00 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
SUB10846MIG
Created by
admin on Mon Mar 31 18:33:00 GMT 2025 , Edited by admin on Mon Mar 31 18:33:00 GMT 2025
|
PRIMARY | |||
|
C76815
Created by
admin on Mon Mar 31 18:33:00 GMT 2025 , Edited by admin on Mon Mar 31 18:33:00 GMT 2025
|
PRIMARY | |||
|
DTXSID20868927
Created by
admin on Mon Mar 31 18:33:00 GMT 2025 , Edited by admin on Mon Mar 31 18:33:00 GMT 2025
|
PRIMARY | |||
|
CHEMBL2104770
Created by
admin on Mon Mar 31 18:33:00 GMT 2025 , Edited by admin on Mon Mar 31 18:33:00 GMT 2025
|
PRIMARY | |||
|
5436
Created by
admin on Mon Mar 31 18:33:00 GMT 2025 , Edited by admin on Mon Mar 31 18:33:00 GMT 2025
|
PRIMARY | |||
|
3086214
Created by
admin on Mon Mar 31 18:33:00 GMT 2025 , Edited by admin on Mon Mar 31 18:33:00 GMT 2025
|
PRIMARY | |||
|
S05RV1R3LZ
Created by
admin on Mon Mar 31 18:33:00 GMT 2025 , Edited by admin on Mon Mar 31 18:33:00 GMT 2025
|
PRIMARY | |||
|
100000082412
Created by
admin on Mon Mar 31 18:33:00 GMT 2025 , Edited by admin on Mon Mar 31 18:33:00 GMT 2025
|
PRIMARY | |||
|
76816-33-6
Created by
admin on Mon Mar 31 18:33:00 GMT 2025 , Edited by admin on Mon Mar 31 18:33:00 GMT 2025
|
SUPERSEDED | |||
|
85702-89-2
Created by
admin on Mon Mar 31 18:33:00 GMT 2025 , Edited by admin on Mon Mar 31 18:33:00 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |